pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
OVERSEAS · news · pharmadog
← back to OVERSEAS
News mentioning OVERSEAS
74
stories
6h
Earnings roundup: Lilly’s unwavering momentum, Novartis’ rebound and GSK’s waiting game
biopharma dive
1d
Chutes & Ladders—Lilly unifies global markets as 36-year vet Patrik Jonsson retires
fiercebiotech
1d
Lilly can’t stop, won’t stop as revenue climbs 39% thanks to GLP-1 bestsellers
biospace
2d
Biotechs going to market alone must learn to go global
biospace
8d
As H-1B visa changes keep coming, biopharmas adjust hiring approach
biospace
10d
STAT+: Launch prices for new medicines dipped slightly last year but remain high, analysis finds
stat
10d
Antheia gets $80M conditional DOD loan to onshore to the US
endpoints
11d
Sanofi breaks ground on insulin plant after securing German government support
biospace
11d
STAT+: Pharmalittle: We’re reading about Roche investments in Germany, a Gilead bowel disease drug, and more
stat
14d
STAT+: Up and down the ladder: The latest comings and goings
stat
14d
STAT+: Pharmalittle: We’re reading about an HHS peptide push, Trump’s pharma stock holdings, and more
stat
14d
China looks to ban foreign acquisitions of critical biopharma platforms
fiercebiotech
15d
STAT+: Pharmalittle: We’re reading about former FDA head calling DOGE a ‘disaster,’ an AstraZeneca AI deal, and more
stat
15d
STAT+: Trump administration delays new rule that could restrict imported medicines from Canada and overseas
stat
21d
Hengrui has become the go-to source of China biopharma innovation. What’s its secret?
fiercebiotech
22d
Newron reveals 5 deaths in late-stage schizophrenia program as FDA maintains hold
biospace
23d
ARPA-H unveils Surpass program to accelerate and expand clinical trials
fiercebiotech
25d
STAT+: Pharmalittle: We’re reading about a Vaxcyte pneumococcal shot, increasing pharma M&A, and more
stat
25d
Opinion: FDA must ensure American patients can access new and experimental drugs
biospace
28d
STAT+: Up and down the ladder: The latest comings and goings
stat
28d
STAT+: Pharmalittle: We’re reading about the 340B drug pilot program, an obesity drug disappointment, and more
stat
29d
STAT+: Pharmalittle: We’re reading about a plan to lower Medicare drug prices, a Lilly obesity drug, and more
stat
29d
The race for access: How the FAIR Act could reclaim U.S. biotech leadership
biospace
Sep 30, 26
STAT+: Pharmalittle: We’re reading about Beam suing over IP theft, a Trump rule on importing meds, and more
stat
Sep 29, 26
STAT+: Lawmakers urge Trump to rethink new rule that could restrict imported meds from Canada and overseas
stat
Sep 24, 26
Pioneer of China NewCo model sued in US over trade secret misuse, double-dealing
fiercebiotech
Sep 23, 26
STAT+: Pharmalittle: We’re reading about a closing loophole for importing meds, European competitiveness, and more
stat
Sep 23, 26
China’s surging biotech sector represents both competition and lifeline for the US
biospace
Sep 22, 26
Novo targets 10-fold jump in oral Wegovy manufacturing capacity by 2030
biospace
Sep 21, 26
Pfizer, Lilly 'most favored nation' deals to give US share of raised foreign prices
endpoints
← prev
page 1 of 3
next →
